SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Bruzelius, M. Bottai, M. Sabater-Lleal, R. J. Strawbridge, A. Bergendal, A. Silveira, A. Sundström, H. Kieler, A. Hamsten, J. Odeberg, Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors, Journal of Thrombosis and Haemostasis, 2015, 13, 2
  2. 2
    Jane Skov, Johannes J. Sidelmann, Else-Marie Bladbjerg, Jørgen Jespersen, Jørgen Gram, Difference in fibrinolytic capacity in young patients with venous thrombosis or ischaemic stroke, Blood Coagulation & Fibrinolysis, 2014, 25, 1, 61

    CrossRef

  3. 3
    R. E. J. Roach, S. C. Cannegieter, W. M. Lijfering, Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment, Journal of Thrombosis and Haemostasis, 2014, 12, 10
  4. 4
    Aerin Kwon, Sang-Ho Jo, Yun-A Jo, Ji-Young Park, Miyoung Kim, Hee Jung Kang, Han-Sung Kim, Hyoun Chan Cho, Young Kyung Lee, Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathway inhibitor in venous thromboembolism, Blood Coagulation & Fibrinolysis, 2014, 25, 5, 416

    CrossRef

  5. 5
    Clifford M. Takemoto, Sajeet Sohi, Kruti Desai, Raman Bharaj, Anuj Khanna, Susan McFarland, Sybil Klaus, Alia Irshad, Neil A. Goldenberg, John J. Strouse, Michael B. Streiff, Hospital-Associated Venous Thromboembolism in Children: Incidence and Clinical Characteristics, The Journal of Pediatrics, 2014, 164, 2, 332

    CrossRef

  6. 6
    N. C. Olson, M. Cushman, P. L. Lutsey, L. A. McClure, S. Judd, R. P. Tracy, A. R. Folsom, N. A. Zakai, Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort, Journal of Thrombosis and Haemostasis, 2014, 12, 12
  7. 7
    P. S. Ghalaut, Joginder Duhan, Vikas Chaudhary, Hemant Krishan Dahiya, Sumin Kaushik, Manisha Sharma, Jitendra Kumar Pehalajani, Ischemic Stroke in a Patient with Hetrozygous Factor V Leiden Mutation: An Uncommon Association, Indian Journal of Hematology and Blood Transfusion, 2014, 30, S1, 335

    CrossRef

  8. 8
    W.-S. Chung, C.-L. Lin, S.-N. Chang, C.-C. Lu, C.-H. Kao, Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study, Journal of Thrombosis and Haemostasis, 2014, 12, 4
  9. 9
    Ashfaque A. Memon, Kristina Sundquist, Xiao Wang, Peter J. Svensson, Jan Sundquist, Bengt Zöller, Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism, Journal of Thrombosis and Thrombolysis, 2014, 38, 3, 348

    CrossRef

  10. 10
    Guochun Chen, Hong Liu, Fuyou Liu, A glimpse of the glomerular milieu: From endothelial cell to thrombotic disease in nephrotic syndrome, Microvascular Research, 2013, 89, 1

    CrossRef

  11. 11
    Wei Shen, Yi Gu, Rui Zhu, Lan Zhang, Jiwei Zhang, Chunmei Ying, Copy number variations of the F8 gene are associated with venous thromboembolism, Blood Cells, Molecules, and Diseases, 2013, 50, 4, 259

    CrossRef

  12. 12
    Suzanne C. Cannegieter, Frits R. Rosendaal, Pregnancy and travel-related thromboembolism, Thrombosis Research, 2013, 131, S55

    CrossRef

  13. 13
    Daniel D. Ribeiro, Willem M. Lijfering, Sandhi M. Barreto, Fabiane Dias Lopes, Giselli de Souza Pires, Frits R. Rosendaal, Suely M. Rezende, Risk of recurrent venous thrombosis related to past provoking risk situations, Blood Coagulation & Fibrinolysis, 2013, 24, 5, 562

    CrossRef

  14. 14
    G. OCAK, C. Y. VOSSEN, M. VERDUIJN, F. W. DEKKER, F. R. ROSENDAAL, S. C. CANNEGIETER, W. M. LIJFERING, Risk of venous thrombosis in patients with major illnesses: results from the MEGA study, Journal of Thrombosis and Haemostasis, 2013, 11, 1
  15. 15
    G. Plu-Bureau, La Contraception en Pratique, 2013,

    CrossRef

  16. 16
    Jeffrey I. Weitz, John W. Eikelboom, Vascular Medicine: A Companion to Braunwald's Heart Disease, 2013,

    CrossRef

  17. 17
    J.-C. Gris, S. Bouvier, N. Molinari, J.-P. Galanaud, E. Cochery-Nouvellon, E. Mercier, P. Fabbro-Peray, J.-P. Balducchi, P. Mares, I. Quere, M. Dauzat, Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study, Blood, 2012, 119, 11, 2624

    CrossRef

  18. 18
    Y. I. G. V. Tichelaar, H. J. C. Kluin-Nelemans, K. Meijer, Infections and inflammatory diseases as risk factors for venous thrombosis, Thrombosis and Haemostasis, 2012, 107, 5, 827

    CrossRef

  19. 19
    Luke Marsden, Angela Cox, Mike Makris, Martina E. Daly, Lack of association between polymorphisms in the interleukin-1 gene cluster and familial thrombophilia, Thrombosis Research, 2012, 129, 5, 629

    CrossRef

  20. 20
    Bengt Zöller, Xinjun Li, Jan Sundquist, Kristina Sundquist, Neighborhood deprivation and hospitalization for venous thromboembolism in Sweden, Journal of Thrombosis and Thrombolysis, 2012, 34, 3, 374

    CrossRef

  21. 21
    Meyer M. Samama, Sophie Combe, Jacqueline Conard, Marie-Helene Horellou, Risk assessment models for thromboprophylaxis of medical patients, Thrombosis Research, 2012, 129, 2, 127

    CrossRef

  22. You have free access to this content22
    Jiří Masopust, Radovan Malý, Martin Vališ, Risk of venous thromboembolism during treatment with antipsychotic agents, Psychiatry and Clinical Neurosciences, 2012, 66, 7
  23. 23
    Bengt Zöller, Xinjun Li, Jan Sundquist, Kristina Sundquist, Risk of venous thromboembolism in first- and second-generation immigrants in Sweden, European Journal of Internal Medicine, 2012, 23, 1, 40

    CrossRef

  24. 24
    Bengt Zöller, Xinjun Li, Jan Sundquist, Kristina Sundquist, Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: A nationwide epidemiological study, Thrombosis Research, 2012, 129, 5, 577

    CrossRef

  25. 25
    Carolina Sales Vieira, Wellington P. Martins, Janaína Boldrini França Fernandes, Gustavo Mafaldo Soares, Rosana Maria dos Reis, Marcos Felipe Silva de Sá, Rui Alberto Ferriani, The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome, Contraception, 2012, 86, 3, 268

    CrossRef

  26. 26
    Daniel D. Ribeiro, Willem M. Lijfering, Sandhi M. Barreto, Fabiane Dias Lopes, Giselli de Souza Pires, Frits R. Rosendaal, Suely M. Rezende, The influence of prothrombotic laboratory abnormalities on the risk of recurrent venous thrombosis, Thrombosis Research, 2012, 130, 6, 974

    CrossRef

  27. 27
    Jan Schmitges, Quoc-Dien Trinh, Maxine Sun, Firas Abdollah, Marco Bianchi, Lars Budäus, Georg Salomon, Thorsten Schlomm, Paul Perrotte, Shahrokh F. Shariat, Francesco Montorsi, Mani Menon, Markus Graefen, Pierre I. Karakiewicz, Venous thromboembolism after radical prostatectomy: the effect of surgical caseload, BJU International, 2012, 110, 6
  28. 28
    P. J. LENTING, C. CASARI, O. D. CHRISTOPHE, C. V. DENIS, von Willebrand factor: the old, the new and the unknown, Journal of Thrombosis and Haemostasis, 2012, 10, 12
  29. 29
    Peter Clark, Olivia Wu, ABO blood groups and thrombosis: a causal association, but is there value in screening?, Future Cardiology, 2011, 7, 2, 191

    CrossRef

  30. 30
    Daniel D. Ribeiro, Willem M. Lijfering, Sandhi M. Barreto, Izabella B.R. Silva, Mariana M.B.S. Chalup, Frits R. Rosendaal, Suely M. Rezende, Past provoking venous thrombosis risk situations on the risk of a recurrent thrombotic event: A cohort study, Thrombosis Research, 2011, 128, 3, 227

    CrossRef

  31. 31
    Rachel E.J. Roach, Sara Roshani, Karina Meijer, Karly Hamulyák, Willem M. Lijfering, Martin H. Prins, Harry R. Büller, Saskia Middeldorp, Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort study, British Journal of Haematology, 2011, 153, 1
  32. 32
    Su-Jin Seok, Su-Ji Kim, Hyo-Wook Gil, Jong-Oh Yang, Eun-Young Lee, Sae-Yong Hong, Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication, Journal of Korean Medical Science, 2011, 26, 4, 474

    CrossRef

  33. 33
    S. C. CHRISTIANSEN, W. M. LIJFERING, F. M. HELMERHORST, F. R. ROSENDAAL, S. C. CANNEGIETER, Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event, Journal of Thrombosis and Haemostasis, 2010, 8, 10
  34. 34
    Meyer Michel Samama, Jacqueline Conard, Grigoris Gerotziafas, Prevention and Treatment of Venous and Arterial Thrombosis in Patients with Specific Conditions: Diabetes, Hypercoagulable States, Pregnancy, and Renal Insufficiency,